Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors

2010-07-15

Additional Metadata
Keywords	Improving PRRT and future directions, Peptide Receptor Radionuclide Therapy (PRRT) in patients - with somatostatin receptor-positive neuroendocrine tumors, PRRT with radiolabeled somatostatin analogues - treatment modality for patients with inoperable or metastasized endocrine GEP tumors
Persistent URL	doi.org/10.1002/9780470613214.ch4, hdl.handle.net/1765/85231
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Essen, M, Kwekkeboom, D, de Herder, W.W, Bodei, L, Kam, B.L, de Jong, M, … Krenning, E.P. (2010). Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors. doi:10.1002/9780470613214.ch4

Publication